Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for AMISULPRIDE
- Study on the Bioequivalence of Amisulpride Orally Disintegrating Tablets in Human Body
- A Comparison of the Efficacy of Amisulpride and Placebo in the Prevention of PONV in Patients at Moderate-to-high Risk of PONV.
- A Study of Intravenous (IV) Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients
- Effects of a Single Dose of Amisulpride on Functional Brain Changes
- Low Dose Amisulpride Vs Olanzapine-Fluoxetine Combination in Post-Schizophrenic Depression
- PK Study of IV and Oral Amisulpride in Subjects With Severe Renal Impairment
- Add-on MEmaNtine to Dopamine Antagonism to Improve Negative Symptoms at First Psychosis
- Psychobiological Mechanisms Underlying Chronic Pain
- Study on the Gut Microbial Mechanism of Negative Symptoms of Schizophrenia
- Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building
- Amisulpride Treatment for BPSD in AD Patients
- Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
- Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults
- Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia Nervosa
- Influence of Dopaminergic Blockade on Stress Responses, Motivation and Emotional Reactivity in Humans.
- Clinical Evaluation of Acupuncture Treatment for Negative Symptoms of Schizophrenia
- Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
- Chinese First Episode Schizophrenia's Optimal Dynamic Antipsychotic Treatment Regime
- Enhancing Recovery in Early Schizophrenia
- [18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis
- Thorough QT Study of Intravenous Amisulpride
- Study of APD421 as PONV Treatment (Prior Prophylaxis)
- Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity
- Study of APD421 as PONV Treatment (no Prior Prophylaxis)
- Pharmacovigilance in Gerontopsychiatric Patients
- Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
- Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
- Metoclopramide as Treatment of Clozapine-induced Hypersalivation
- Association of Amisulpride Response in Schizophrenia With Brain Image
- A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol as a Treatment for Acutely Ill Schizophrenic Patients
- Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study
- US Phase III Study of APD421 in PONV
- European Phase III Study of APD421 in PONV
- Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics
- Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia
- Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis
- Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome
- An Investigation of Early Life Stress and Depression
- A Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of Schizophrenia
- Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy
- Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen
- An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)
- Optimisation of Antipsychotic Drug Use in Older People
- Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia Patients
- Bergen Psychosis Project 2 - The Best Intro Study
- The Effects of Dopamine on Reward Processing
- Optimization of Treatment and Management of Schizophrenia in Europe
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia
- Evaluation of Negative Symptoms and Cognitive Function After Administration of Antipsychotics in Healthy Volunteer
- Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism
- Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)
- Amisulpride Augmentation Therapy for Clozapine-resistant Schizophrenic Patients
- Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia
- Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome
- Tardive Dyskinesia and Cognitive Function
- Efficacy Study on Cognitive Functions in Schizophrenic Patients
- Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis
- Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study
- Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation
- Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors
- Amisulpride in Schizophrenic Acute Phase Patients
- Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy
- Amisulpride in Schizophrenic Patients
- A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication
- SOLIACS: Solian Solution in the Acute Setting
- Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis
- SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I Patients
Clinical trials list
click for details